234 related articles for article (PubMed ID: 17490728)
1. In vivo response to vascular injury in the absence of factor IX: examination in factor IX knockout mice.
Gui T; Reheman A; Funkhouser WK; Bellinger DA; Hagaman JR; Stafford DW; Monahan PE; Ni H
Thromb Res; 2007; 121(2):225-34. PubMed ID: 17490728
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model.
Dubois C; Panicot-Dubois L; Gainor JF; Furie BC; Furie B
J Clin Invest; 2007 Apr; 117(4):953-60. PubMed ID: 17380206
[TBL] [Abstract][Full Text] [Related]
3. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
4. Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity.
Nonne C; Lenain N; Hechler B; Mangin P; Cazenave JP; Gachet C; Lanza F
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1293-8. PubMed ID: 15774906
[TBL] [Abstract][Full Text] [Related]
5. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
Renné T; Nieswandt B; Gailani D
Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
[TBL] [Abstract][Full Text] [Related]
6. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype.
de Boer HC; Verseyden C; Ulfman LH; Zwaginga JJ; Bot I; Biessen EA; Rabelink TJ; van Zonneveld AJ
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1653-9. PubMed ID: 16627804
[TBL] [Abstract][Full Text] [Related]
7. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
Mackman N; Tilley RE; Key NS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
[TBL] [Abstract][Full Text] [Related]
8. In vivo thrombus formation in murine models.
Sachs UJ; Nieswandt B
Circ Res; 2007 Apr; 100(7):979-91. PubMed ID: 17431199
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin acts as an endogenous antithrombotic factor.
Kato H; Kashiwagi H; Shiraga M; Tadokoro S; Kamae T; Ujiie H; Honda S; Miyata S; Ijiri Y; Yamamoto J; Maeda N; Funahashi T; Kurata Y; Shimomura I; Tomiyama Y; Kanakura Y
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):224-30. PubMed ID: 16269667
[TBL] [Abstract][Full Text] [Related]
10. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
[TBL] [Abstract][Full Text] [Related]
11. [Interaction of blood and the vascular wall: hemostatic aspects].
Gerlach E; Becker BF
Z Kardiol; 1993; 82 Suppl 5():13-21. PubMed ID: 8154153
[TBL] [Abstract][Full Text] [Related]
12. Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis.
Evans DJ; Jackman LE; Chamberlain J; Crosdale DJ; Judge HM; Jetha K; Norman KE; Francis SE; Storey RF
Circulation; 2009 Jan; 119(1):116-22. PubMed ID: 19103996
[TBL] [Abstract][Full Text] [Related]
13. The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces.
Ruggeri ZM
Thromb Haemost; 1995 Jul; 74(1):460-3. PubMed ID: 8578507
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen.
Lwaleed BA; Greenfield RS; Hicks J; Birch BR; Cooper AJ
J Androl; 2005; 26(1):146-52. PubMed ID: 15611579
[TBL] [Abstract][Full Text] [Related]
15. Factor IX: Insights from knock-out and genetically engineered mice.
Monahan PE
Thromb Haemost; 2008 Oct; 100(4):563-75. PubMed ID: 18841277
[TBL] [Abstract][Full Text] [Related]
16. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
[TBL] [Abstract][Full Text] [Related]
17. An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice.
Begbie ME; Mamdani A; Gataiance S; Eltringham-Smith LJ; Bhakta V; Hortelano G; Sheffield WP
Thromb Haemost; 2005 Dec; 94(6):1138-47. PubMed ID: 16411385
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the factor IX epidermal growth factor-like domain mutation Ile66Thr associated with mild hemophilia B.
Knobe KE; Persson KE; Sjörin E; Villoutreix BO; Ljung RC
Pathophysiol Haemost Thromb; 2006; 35(5):370-5. PubMed ID: 17230038
[TBL] [Abstract][Full Text] [Related]
19. Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.
Swieringa F; Kuijpers MJ; Lamers MM; van der Meijden PE; Heemskerk JW
Haematologica; 2015 Jun; 100(6):748-56. PubMed ID: 25769543
[TBL] [Abstract][Full Text] [Related]
20. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
